FDA is requiring weight loss drug makers to add a vision loss warning
The warning covers all GLP-1 drugs, including Ozempic, Wegovy, Mounjaro and Zepbound, over a rare eye condition called NAION
We haven't written up this one. Quartz has the full story — the link below goes straight to it.